| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GLAUKOS Corp | Director | Common Stock | 21,439 | $2,420,679 | $112.91 | 02 Jan 2026 | Direct |
| GLAUKOS Corp | Director | Stock Option (Right to Buy) | 3,149 | $86,348 | $69.30 | 29 May 2025 | Direct |
| UroGen Pharma Ltd. | Director | ordinary shares | 2,000 | $39,560 | $19.78 | 26 Nov 2025 | Direct |
| UroGen Pharma Ltd. | Director | Stock Option (right ot buy) | 10,000 | 26 Aug 2025 | Direct | ||
| UroGen Pharma Ltd. | Director | Restricted Stock Unit | 6,000 | 26 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GKOS | GLAUKOS Corp | 02 Jan 2026 | 1 | $0 | 4 | Director | 07 Jan 2026, 19:18 |
| URGN | UroGen Pharma Ltd. | 26 Nov 2025 | 2 | $0 | 4 | Director | 01 Dec 2025, 16:46 |
| URGN | UroGen Pharma Ltd. | 26 Aug 2025 | 2 | $0 | 4 | Director | 27 Aug 2025, 16:37 |
| GKOS | GLAUKOS Corp | 02 Jan 2025 | 3 | $0 | 4 | Director | 02 Jun 2025, 16:39 |
| URGN | UroGen Pharma Ltd. | 06 Aug 2024 | 1 | $0 | 4 | Director | 08 Aug 2024, 09:07 |
| GKOS | GLAUKOS Corp | 30 May 2024 | 2 | $0 | 4 | Director | 03 Jun 2024, 20:56 |
| URGN | UroGen Pharma Ltd. | 07 Sep 2023 | 1 | $0 | 4 | Director | 08 Sep 2023, 16:41 |
| GKOS | GLAUKOS Corp | 01 Jun 2023 | 1 | $0 | 4 | Director | 05 Jun 2023, 20:15 |
| GKOS | GLAUKOS Corp | 03 Jan 2023 | 1 | $0 | 4 | Director | 04 Jan 2023, 17:21 |
| GKOS | GLAUKOS Corp | 03 Jan 2023 | 1 | $0 | 4 | Director | 04 Jan 2023, 17:16 |
| URGN | UroGen Pharma Ltd. | 08 Sep 2022 | 0 | $0 | 3 | Director | 12 Sep 2022, 08:29 |
| URGN | UroGen Pharma Ltd. | 08 Sep 2022 | 1 | $0 | 4 | Director | 12 Sep 2022, 08:28 |
| GKOS | GLAUKOS Corp | 02 Jun 2022 | 1 | $0 | 4 | Director | 06 Jun 2022, 19:57 |
| GKOS | GLAUKOS Corp | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 19:59 |
| GKOS | GLAUKOS Corp | 03 Jun 2021 | 1 | $0 | 4 | Director | 07 Jun 2021, 18:47 |